Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.

Scientists have created the first detailed day-by-day map of human embryo development using single-cell technology.

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

Oliver Bathe walks through addressing the surge in papillary thyroid cancer incidence by refining cancer care through ...

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Scientists announced the Biodiversity Cell Atlas project to map every cell type across all eukaryotic life on Earth.

Novel approach could apply to multiple types of allergy, including food allergies, and may become an alternative to routine ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

We used single-nucleus RNA-seq to determine which genes were expressed differently ... or therapeutic benefits for individuals at high risk of Alzheimer's disease. Of course, more laboratory and ...

For decades, the story of prostate cancer screening has been dominated by three letters: P-S-A. The Prostate-Specific Antigen blood test is the first line of defense for millions of men. Yet, for all ...

Next, Dr. Mouw addressed the secondary analysis of the RAVES trial, which compared adjuvant and early salvage radiotherapy in ...

Cas9, genome editing has been revolutionized by the ability to introduce targeted genetic changes with unprecedented ...